Top

Gepubliceerd in:

01-08-2009

Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population

Auteurs: Trude Haugland, Morten H. Vatn, Marijke Veenstra, Astrid Klopstad Wahl, Gerd Karin Natvig

Gepubliceerd in: Quality of Life Research | Uitgave 6/2009

Abstract

Purpose

Health related quality of life (HRQoL) was characterized among patients with neuroendocrine tumor (NET) and compared with the general Norwegian population.

Methods

A cross sectional, comparative design was chosen, and the samples comprised 196 NET patients and 5,258 individuals from the general Norwegian population.

We used Chi-square cross tab calculations to evaluate sociodemographic characteristics, T-tests for independent samples and Analysis of Variance (ANOVA) in order to compare HRQoL (SF-36) scores across a range of background variables. Furthermore, T-tests were used to analyze differences in HRQoL scores between the samples.

Results

NET patients demonstrated significantly lower on all HRQoL subscales when compared with the general population with the lowest values on general health, physical limitation and vitality. Individuals above 70 years reported lower scores on physical functioning and physical limitations compared with those who were younger. Individuals with higher levels of education reported increased physical functioning compared with those with less education and full-time or part-time workers described higher physical functioning and less physical limitations compared with those who were retired.

Conclusions

All SF-36 HRQoL scores were significantly lower among the NET patients when compared with the general population. Assistance from health personnel to NET patients should focus on those domains.

vorige artikel Health-related quality of life and help seeking among American Indians with diabetes and hypertension

volgende artikel Reliability and validity of the SF-12v2 in the medical expenditure panel survey

Oberg, K. (2003). Diagnosis and treatment of carcinoid tumors. Expert Review of Anticancer Therapy, 3(6), 863–877. doi:10.1586/14737140.3.6.863. Review 134 refs.PubMedCrossRef

Oberg, K. (1994). Endocrine tumors of the gastrointestinal tract: Systemic treatment. Anti-Cancer Drugs, 5(5), 503–519. doi:10.1097/00001813-199410000-00001. Review 93 refs.PubMedCrossRef

Knox, C. D., Feurer, I. D., Wise, P. E., Lamps, L. W., Kelly, W. J., Chari, R. S., et al. (2004). Survival and functional quality of life after resection for hepatic carcinoid metastasis. Journal of Gastrointestinal Surgery, 8(6), 653–659. doi:10.1016/j.gassur.2004.04.003.PubMedCrossRef

Norheim, I., Oberg, K., Theodorsson-Norheim, E., Lindgren, P. G., Lundqvist, G., Magnusson, A., et al. (1987). Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Annals of Surgery, 206(2), 115–125.PubMedCrossRef

Ware, J. E., Jr., Kosinski, M., & Keller, S. D. (1994). SF-36 Physical and mental health summary scales: A user’s manual (5th ed.). Boston, MA: Health Assessment Lab

Larsson, G., Von Essen, L., & Sjoden, P. O. (1998). Quality of life in patients with endocrine tumors of the gastrointestinal tract: Patient and staff perceptions. Cancer Nursing, 21(6), 411–420. doi:10.1097/00002820-199812000-00005.PubMedCrossRef

Larsson, G., Widmark, P. V., Lampic, C., von Essen, L., & Sjoden, P. O. (1998). Cancer patient and staff ratings of the importance of caring behaviors and their relations to patient anxiety and depression. Journal of Advanced Nursing, 27(4), 855–864. doi:10.1046/j.1365-2648.1998.00583.x.PubMedCrossRef

Ramage, J. K., & Davies, A. H. (2003). Measurement of quality of life in carcinoid/neuroendocrine tumours. Endocrine-Related Cancer, 10(4), 483–486. doi:10.1677/erc.0.0100483.PubMedCrossRef

Larsson, G., Sjoden, P. O., Oberg, K., Eriksson, B., & Von Essen, L. (2001). Health-related quality of life, anxiety and depression in patients with midgut carcinoid tumours. Acta Oncologica, 40(7), 825–831. doi:10.1080/02841860152703445.PubMedCrossRef

10.

Frojd, C., Larsson, G., Lampic, C., & von Essen, L. (2007). Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study. Health and Quality of Life Outcomes, 5, 18. doi:10.1186/1477-7525-5-18.PubMedCrossRef

11.

Berglund, G., Liden, A., Hansson, M. G., Oberg, K., Sjoden, P. O., & Nordin, K. (2003). Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1). Familial Cancer, 2(1), 27–33. doi:10.1023/A:1023252107120. Erratum appears in Fam Cancer. 2003;2(2):151.PubMedCrossRef

12.

Larsson, G., Sjoden, P. O., Oberg, K., & von Essen, L. (1999). Importance-satisfaction discrepancies are associated with health-related quality of life in five-year survivors of endocrine gastrointestinal tumours. Annals of Oncology, 10(11), 1321–1327. doi:10.1023/A:1008360718646.PubMedCrossRef

13.

Hjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998). Using reference data on quality of life—the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). European Journal of Cancer, 34(9), 1381–1389. doi:10.1016/S0959-8049(98)00136-1.PubMedCrossRef

14.

McHorney, C. A., Ware, J. E., Jr., Lu, J. F., & Sherbourne, C. D. (1994). The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32(1), 40–66. doi:10.1097/00005650-199401000-00004.PubMedCrossRef

15.

Norwegian Social Sience data Services (NSD). (2003). SF-36 data from the General population (n = 5152). Norway, The Norwegian Social Science Data Services, The Norwegian Survey Archive (www.nsd-uib.no/english/2006).

16.

Albert, S. M., Frank, L., Kleinman, L., Leidy, N. K., Legro, M., Shikiar, R., et al. (1998). Defining and measuring quality of life in medicine. JAMA. Journal of the American Medical Association, 279(6), 429–431. doi:10.1001/jama.279.6.429.PubMedCrossRef

17.

Davies, A. H. G., Larsson, G., Ardill, J., Friend, E., Jones, L., Falconi, M., et al. (2006). Development of a disease-specific quality of life questionnaire module for patients with gastrointestinal neuroendocrine tumours. European Journal of Cancer, 42(4), 477–484. doi:10.1016/j.ejca.2005.10.025.PubMedCrossRef

18.

Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483. doi:10.1097/00005650-199206000-00002.PubMedCrossRef

19.

Loge, J. H., & Kaasa, S. (1998). Short form 36 (SF-36) health survey: Normative data from the general Norwegian population. Scandinavian Journal of Social Medicine, 26(4), 250–258.PubMed

20.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press.

21.

King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555–567. doi:10.1007/BF00439229. Review 35 refs.PubMedCrossRef

22.

Mols, F., Aaronson, N. K., Vingerhoets, A. J., Coebergh, J. W., Vreugdenhil, G., Lybeert, M. L., et al. (2007). Quality of life among long-term non-Hodgkin lymphoma survivors: A population-based study. Cancer, 109(8), 1659–1667. doi:10.1002/cncr.22581.PubMedCrossRef

23.

Boini, S., Briancon, S., Guillemin, F., Galan, P., & Hercberg, S. (2004). Impact of cancer occurrence on health-related quality of life: A longitudinal pre-post assessment. Health and Quality of Life Outcomes, 2, 4. doi:10.1186/1477-7525-2-4.PubMedCrossRef

24.

Hammerlid, E., & Taft, C. (2001). Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms. British Journal of Cancer, 84(2), 149–156. doi:10.1054/bjoc.2000.1576.PubMedCrossRef

25.

Saegrov, S., & Halding, A. G. (2004). What is it like living with the diagnosis of cancer? European Journal of Cancer Care, 13(2), 145–153. doi:10.1111/j.1365-2354.2004.00442.x.PubMedCrossRef

26.

Tan, L. G., Nan, L., Thumboo, J., Sundram, F., & Tan, L. K. (2007). Health-related quality of life in thyroid cancer survivors. The Laryngoscope, 117(3), 507–510. doi:10.1097/MLG.0b013e31802e3739.PubMedCrossRef

27.

Oberg, K., Astrup, L., Eriksson, B., Falkmer, S. E., Falkmer, U. G., Gustafsen, J., et al. (2004). Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types. Acta Oncologica, 43(7), 626–636. doi:10.1080/02841860410018584.PubMedCrossRef

28.

Oberg, K., Astrup, L., Eriksson, B., Falkmer, S. E., Falkmer, U. G., Gustafsen, J., et al. (2004). Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncologica, 43(7), 617–625. doi:10.1080/02841860410018575.PubMedCrossRef

29.

Oberg, K., & Eriksson, B. (1989). Medical treatment of neuroendocrine gut and pancreatic tumors. Acta Oncologica, 28(3), 425–431. doi:10.3109/02841868909111217 (Review 32 refs).PubMedCrossRef

Titel: Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population
Auteurs: Trude Haugland
Morten H. Vatn
Marijke Veenstra
Astrid Klopstad Wahl
Gerd Karin Natvig
Publicatiedatum: 01-08-2009
Uitgeverij: Springer Netherlands
Gepubliceerd in: Quality of Life Research / Uitgave 6/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-009-9487-x

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2009

Measuring patient satisfaction in oncology palliative care: psychometric properties of the FAMCARE-patient scale

Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample

Reliability and validity of the SF-12v2 in the medical expenditure panel survey

Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia

The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW

Measurement accuracy in assessing patient’s quality of life: to weight or not to weight domains of quality of life